NF-"TR"GLP-2 30MG

Synthetic peptide investigated for dual-receptor incretin pathway activity, with a more focused mechanism relevant to glucose-metabolism and energy-balance research models.

Research Focus:

• Glycemic Regulation — Studied for glucose-dependent insulin secretion.

• Satiety Signaling — Investigated for appetite-regulating pathways.

• Body Composition — Examined for fat-mass and lean-mass ratios.

• Metabolic Flexibility — Studied for substrate-switching pathways.

• Insulin Sensitivity — Investigated for insulin-signaling endpoints.

• Dual-Incretin Pharmacology — Studied for dual-receptor co-agonism vs mono-agonists.

• Metabolic-Rate Research — Investigated for energy-expenditure and thermogenesis pathways.

RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

Not for human or veterinary use. Sold exclusively as a reference material for in-vitro and in-vivo laboratory research. Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent any disease.